154 related articles for article (PubMed ID: 9781987)
21. Comparison of cytokine levels in bilateral ear effusions in patients with otitis media secretoria.
Matkovic S; Vojvodic D; Baljosevic I
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):450-3. PubMed ID: 17765774
[TBL] [Abstract][Full Text] [Related]
22. The role of gastric pepsin in the inflammatory cascade of pediatric otitis media.
O'Reilly RC; Soundar S; Tonb D; Bolling L; Yoo E; Nadal T; Grindle C; Field E; He Z
JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):350-7. PubMed ID: 25633964
[TBL] [Abstract][Full Text] [Related]
23. Determining otitis media severity from middle ear fluid analysis.
Juhn SK; Garvis WJ; Lees CJ; Le CT; Kim CS
Ann Otol Rhinol Laryngol Suppl; 1994 May; 163():43-5. PubMed ID: 8179269
[TBL] [Abstract][Full Text] [Related]
24. Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection.
Nell MJ; Grote JJ
Laryngoscope; 1999 Nov; 109(11):1815-9. PubMed ID: 10569413
[TBL] [Abstract][Full Text] [Related]
25. Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion.
Smirnova MG; Kiselev SL; Gnuchev NV; Birchall JP; Pearson JP
Eur Cytokine Netw; 2002; 13(2):161-72. PubMed ID: 12101072
[TBL] [Abstract][Full Text] [Related]
26. [Interleukin-6 and tumor necrosis factor-alpha in middle ear effusions].
Xie M; Zhou L; Jin X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):280-2. PubMed ID: 10743092
[TBL] [Abstract][Full Text] [Related]
27. Characterization of otitis media with effusion based on the ratio of albumin and immunoglobulin G concentrations in the effusion.
Rezes S; Késmárki K; Sipka S; Sziklai I
Otol Neurotol; 2007 Aug; 28(5):663-7. PubMed ID: 17667774
[TBL] [Abstract][Full Text] [Related]
28. Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media.
Russo E; Smith CW; Friedman EM; Smith EO; Kaplan SL
Otolaryngol Head Neck Surg; 2004 Feb; 130(2):242-8. PubMed ID: 14990922
[TBL] [Abstract][Full Text] [Related]
29. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
Zhao SQ; Li J; Liu H; Zhang QG; Wang Y; Han DM
Chin Med J (Engl); 2009 Sep; 122(18):2149-54. PubMed ID: 19781301
[TBL] [Abstract][Full Text] [Related]
30. Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion.
Smirnova MG; Birchall JP; Pearson JP
Acta Otolaryngol; 2005 Oct; 125(10):1043-50. PubMed ID: 16298784
[TBL] [Abstract][Full Text] [Related]
31. Role of interleukin-1beta in a murine model of otitis media with effusion.
Watanabe T; Hirano T; Suzuki M; Kurono Y; Mogi G
Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):574-80. PubMed ID: 11407850
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of major basic protein (MBP) and interleukin-5(IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion.
Wright ED; Hurst D; Miotto D; Giguere C; Hamid Q
Otolaryngol Head Neck Surg; 2000 Nov; 123(5):533-8. PubMed ID: 11077335
[TBL] [Abstract][Full Text] [Related]
33. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection.
Hebda PA; Piltcher OB; Swarts JD; Alper CM; Zeevi A; Doyle WJ
Laryngoscope; 2002 Sep; 112(9):1657-62. PubMed ID: 12352682
[TBL] [Abstract][Full Text] [Related]
34. Compositional difference in middle ear effusion: mucous versus serous.
Chung MH; Choi JY; Lee WS; Kim HN; Yoon JH
Laryngoscope; 2002 Jan; 112(1):152-5. PubMed ID: 11802055
[TBL] [Abstract][Full Text] [Related]
35. Effects of Allergina on the treatment of otitis media with effusions.
Jeong HJ; Hong SH; Kim SC; Park EJ; Jang CH; Kim KS; Kim HM
Inflammation; 2002 Apr; 26(2):89-95. PubMed ID: 11989792
[TBL] [Abstract][Full Text] [Related]
36. The levels of IL-1 beta in human middle ear effusions.
Juhn SK; Tolan CT; Garvis WJ; Cross DS; Giebink GS
Acta Otolaryngol Suppl; 1992; 493():37-42. PubMed ID: 1636421
[TBL] [Abstract][Full Text] [Related]
37. Characterization of mucoid and serous middle ear effusions from patients with chronic otitis media: implication of different biological mechanisms?
Val S; Poley M; Anna K; Nino G; Brown K; Pérez-Losada M; Gordish-Dressman H; Preciado D
Pediatr Res; 2018 Aug; 84(2):296-305. PubMed ID: 29915406
[TBL] [Abstract][Full Text] [Related]
38. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
Yetiser S; Satar B; Aydin N
Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
[TBL] [Abstract][Full Text] [Related]
39. Studying the Serum as Well as Serous Level of IL-17 and IL-23 in Patients with Serous Otitis Media.
Yeghaneh Moghaddam A; Talaei R; Nikoueinejad H; Akbari H
Iran J Allergy Asthma Immunol; 2017 Dec; 16(6):520-524. PubMed ID: 29338158
[TBL] [Abstract][Full Text] [Related]
40. TH1/TH2 and regulatory cytokines in adults with otitis media with effusion.
Kariya S; Okano M; Hattori H; Sugata Y; Matsumoto R; Fukushima K; Schachern PA; Cureoglu S; Paparella MM; Nishizaki K
Otol Neurotol; 2006 Dec; 27(8):1089-93. PubMed ID: 16988618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
